Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NEUVÉ Health vs Strut Health

By GLP-1 ScorecardUpdated

NEUVÉ HealthFactor scores not reassessed.
Site position #251

Lower score

Strut HealthFactor scores not reassessed.
Site position #26

Higher score

Score comparison

Strut Health has the higher recorded score — 79.4/100 to 64.7/100.

Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

Before you choose

NEUVÉ Health does not publish a semaglutide price, so its NEUVÉ Health review sets out what it does disclose, while the Strut Health review explains the conditions attached to Strut Health's figure. The semaglutide cost page compares published rates across the field. Ask NEUVÉ Health for a written total before treating either one as the cheaper choice.

If neither one fits, NEUVÉ Health vs telos rx and Nolu vs Strut Health compare each of them with another graded program, and the list of alternatives to NEUVÉ Health ranks the programs closest to NEUVÉ Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueStrut Health +41
49
90
Dose & formulationStrut Health +20
75
95
Clinical oversightNEUVÉ Health +14
69
55
Labs & monitoringNEUVÉ Health +13
73
60
FulfillmentStrut Health +12
76
88
Contract termsStrut Health +47
45
92
NEUVÉ Health · top barStrut Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNEUVÉ HealthStrut Health
WeighScore64.7/10079.4/100
GradeCC+
Site position#251#26
SemaglutideConfirm total including separate labsOral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal
TirzepatideConfirm total including separate labsOral $199/30 days; injection from $149/mo depending on prescribed dose—confirm quantity and renewal
CoverageAll 50 states advertised; treatment availability variesFAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
NEUVÉ Health

Site position #251 · C

Factor scores not reassessed.

Strengths

  • Lists microdose and standard injections separately
  • Explains which party handles membership and treatment refunds

What to consider

  • The GLP-1 price table excludes required labs
  • The membership refund policy does not establish pharmacy or laboratory refund terms
Strut Health

Site position #26 · C+

Factor scores not reassessed.

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Strengths

  • Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
  • Provider consultations, follow-ups and shipping are advertised as included
  • Current help describes an account cancellation button; terms also provide an email route
  • Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription

What to consider

  • Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
  • Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
  • 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
  • Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024

Featured provider

Strut Health

Factor scores not reassessed.

Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard